SGLT2 Inhibitors Linked to Lower Gout Medication Need in T2D
The use of SGLT2 inhibitors (SGLT2i) was associated with fewer gout flares and reduced use of gout medication among adults with both gout and type 2 diabetes (T2D), according to results of a new study. “In addition to the acutely painful joint flares, gout …